In 2026, advanced therapies diverge: winners pair proven biology with scalable manufacturing, delivery, and workflow fit, while others advance more slowly under operational and economic limits.
- In Vivo's Biggest Threat — Comparison To Old Models
- The 5-Layer Fix For AI Failure In Pharmaceutical Manufacturing
- Why Use Total Organic Carbon Analysis For Cleaning Validation?
- December 2025 — CDMO Opportunities And Threats Report
- The Great Cell Therapy Reset: Solving The Industrial Math Of Living Drugs
- Single-Use Standards Are Maturing, But The Process Remains King
- ARM's Tim Hunt On Expanding Patient Access, Smarter Regulation, And A More Sustainable Market In 2026
- Deploying A Vendor Life Cycle Oversight Model
CELL & GENE ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![GettyImages-499481438 isolator]( "Turnkey Dismantling, Modification, And Relocation Of A Multi-Glove Isolator System")
Turnkey Dismantling, Modification, And Relocation Of A Multi-Glove Isolator SystemStrategic equipment relocation and retrofitting can reduce capital costs by fifty percent and save months in lead time. Learn how to modernize legacy systems while maintaining full GMP compliance.
-
![mRNA GettyImages-1356994684]( "Elevating mRNA Manufacturing Toward GMP-Readiness")
Elevating mRNA Manufacturing Toward GMP-ReadinessThe mRNA Technology Transfer Program empowers LMICs with scalable vaccine production. Learn about a partnership that drives innovation in mRNA and sets a global blueprint for equitable health access.
-
![2025 business outlook-GettyImages-2179048246]( "What Clinical Trial Decision Makers Are Prioritizing In 2025")
What Clinical Trial Decision Makers Are Prioritizing In 2025In 2025, clinical trial operations are undergoing a transformative shift driven by the need for speed, cost-efficiency, and patient-centered approaches.
-
![GettyImages-1494992361 Woman hands holding intestine shape]( "Studying Gut Inflammation And Barrier Disruption With Organ-On-A-Chip Technology")
Studying Gut Inflammation And Barrier Disruption With Organ-On-A-Chip TechnologySee how the Colon Intestine-Chip has been employed to model cytokine-mediated inflammation and barrier disruption in the intestine.
-
![GettyImages-1343098807-cell-and-gene-dna-helix-modern-hand]( "Advances In Analytical Method Selection And Technology Transfer")
Advances In Analytical Method Selection And Technology TransferSuccessful analytical method transfer is crucial for product quality and regulatory compliance. Learn best practices for tech transfer, including how gap assessments mitigate common risks and streamline bioprocessing.
-
![GettyImages-1185230425-indoc-AAV-petri-dish]( "Novel Engineered Plasmids, Optimized HEK293 Cell Line For AAV Productivity")
Novel Engineered Plasmids, Optimized HEK293 Cell Line For AAV ProductivityLonza has further improved its platform process with the creation of engineered plasmids that afford significantly higher titers and productivity levels compared to standard systems.
-
![GettyImages-2174865889-scientists-laboratory-equipment-analysis]( "Optimized Product Recovery Using The Drug Product Filtration System")
Optimized Product Recovery Using The Drug Product Filtration SystemExplore strategies to maximize drug product recovery during sterile filtration, minimize hold-up volume, and reduce dilution after PUPSIT to ensure higher yield, improved efficiency, and less waste.
-
![GettyImages-1935725164-disease-cell-blue]( "3D Neurospheres In Healthy And Alzheimer's: iPSC-Derived Neurons")
3D Neurospheres In Healthy And Alzheimer's: iPSC-Derived NeuronsExplore how different ApoE alleles influence Alzheimer's Disease risk using iPSC-derived neurons as well as gain insights into AD mechanisms and potential therapies.
-
![Abstract world map-GettyImages-1328650251]( "What the FDA Looks For In Global Development Programs Today")
What the FDA Looks For In Global Development Programs TodayMastering the complexities of multi-regional clinical trials requires aligning global data with evolving regulatory expectations to ensure treatment consistency and successful drug approval.
-
![GettyImages-1425605790 Life Sciences Training. Scientists Using A Computer In A Lab]( "Explore A High-Performing Basal Medium And Feed Pairing")
Explore A High-Performing Basal Medium And Feed PairingA customer sought to replace a chemically defined CHO medium with a more efficient medium and feed pairing strategy in bioreactors.
NEWSLETTER ARCHIVE
- 02.04.26 -- Balancing The Elements: Strategies For Resilient Clinical Research
- 02.04.26 -- In Vivo's Biggest Threat — Comparison To Old Models
- 02.03.26 -- STREAM Edition: Data Governance And Regulations For AI Use In GMP With Peter Baker
- 02.03.26 -- Why Use Total Organic Carbon Analysis For Cleaning Validation?
- 02.02.26 -- 2026 CDMO Forecast: The 7 Shifts Sponsors Need To Prepare For
- Disciplined CGT Will Win On 2026 Regulatory Flexibility
- ARM's Tim Hunt On Expanding Patient Access, Smarter Regulation, And A More Sustainable Market In 2026
- Global Shifts And Strategic Resilience Will Shape CGT In 2026
- Why Efficiency In Multi-Modal CGT Manufacturing Is About Execution, Not Just Cost
- CSL's HEMGENIX Shows Durable Benefit, A New Future For Gene Therapy in Hemophilia B
CELL AND GENE CONTENT COLLECTIONS
While there are opportunities to scale, there are also manufacturing gaps, capacity issues, and production timelines that require improvement to do so. And then, of course, there’s cost. Because scale up and scale out are significant to everyone in the sector, we’ve curated insightful editorial that addresses the most important aspects of scalability.
More Content Collections
